C. Chulak et al., MODULATORY EFFECT OF BRADYKININ ON THE RELEASE OF NORADRENALINE FROM RAT ISOLATED ATRIA, British Journal of Pharmacology, 115(2), 1995, pp. 330-334
1 We investigated the modulation by bradykinin (BK) of electrically in
duced noradrenaline release in rat isolated atria preincubated with [H
-3]-noradrenaline. 2 BK (1-100 nM) enhanced significantly the stimulat
ion-induced outflow of radioactivity in a concentration-dependent mann
er with a calculated EC(50) of 0.58 nM. 3 Des-Arg(9)-BK (0.1-100 nM),
a Selective B-1 receptor agonist, did not modify the stimulation-induc
ed outflow of radioactivity. Hoe 140 (10 nM), a selective B-2 receptor
antagonist, but not [Leu(8)]-des-Arg(9)-BK (100 nM), a selective B-1
receptor antagonist, blocked the facilitatory effect of BK. 4 The effe
ct of BK was not affected by diclofenac (1 mu M), a cyclo-oxygenase in
hibitor. Bisindolylmaleimide (1 mu M), a protein kinase C inhibitor, s
ignificantly reduced the facilitatory effect of BK (10 nM), angiotensi
n II (0.3 mu M) and phorbol dibutyrate (0.1 and 1 mu M) but not of fen
oterol (1 mu M). 5 The results suggest that BK enhances noradrenaline
release via a prejunctional B-2 kinin receptor in the rat atrium. The
effect appears to involve protein kinase C as a second messenger.